Oren Gilad, President & CEO, Director at Aprea Therapeutics, holds 347.42K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Oren Gilad Bought $5,500 shares of Aprea Therapeutics on Apr 04, 2025 for an estimated value of 10.11K.
What is the percentage of profitable transactions made by Oren Gilad?
The percentage of profitable transactions made by Oren Gilad is 20%.
What is the average return per transaction made by Oren Gilad?
The average return per transaction made by Oren Gilad is -40.40%.
What stocks does Oren Gilad hold?
Oren Gilad holds: APRE stocks.
What was Oren Gilad’s latest transaction?
Oren Gilad latest transaction was an Informative Buy of $10.11K.
What was Oren Gilad's most profitable transaction?
Oren Gilad’s most profitable transaction was an Informative Buy of APRE stock on April 4, 2025. The return on the trade was 1.70%.
What is Oren Gilad's role in Aprea Therapeutics?
Oren Gilad's role in Aprea Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.